MedTrace Logo

Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay

NCT03343691 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-08-22

No results posted yet for this study

Summary

Blood samples from a total of 200 women in two cohorts will be collected and analyzed by TM-B1 assay, which is based on TBIA (Total Biochemical Infrared Analysis) to confirm the presence of cancer. These two cohorts will yield 75 healthy women with no pathological findings, 75 women diagnosed as having benign breast tumor and 50 women diagnosed as having breast cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Screening Population

Blood samples taken from screening population

DIAGNOSTIC_TEST

Breast Cancer Population

Blood samples taken from Breast Cancer population

Sponsors & Collaborators

  • Todos Medical, Ltd.

    lead INDUSTRY

Principal Investigators

  • Tanir N Alweis, M.D. · Kaplan Medical Center,Pasternak St., POB 1, Rehovot 76100, Israel

Eligibility

Min Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-22
Primary Completion
2019-05-01
Completion
2019-07-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03343691 on ClinicalTrials.gov